03 January 2018 | News
Atlanta Biologicals is a great fit with the Bio-Techne product to expand cell culture and tissue regeneration capabilities
Bio-Techne Corporation is a leading developer and manufacturer of high quality purified proteins especially cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds.
The company announced that it has acquired all of the stock of Atlanta Biologicals and its affiliated company.
The transaction is financed through available cash on hand.
Atlanta Biologicals was founded in 1992 and has focused on supplying cell culture sera, media and reagents for the life science research market.
The acquisition is expected to be slightly accretive to Bio-Techne's adjusted earnings per share for its fiscal year 2018.
The companies are confident with the strategic fit between them, given their shared commitment to provide quality products and excellent customer service.